Share class: Belluscura plc

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A1401,309,607260,239,119 ( 64.85 %) 0 64.85 %

Major shareholders: Belluscura plc

NameStocks%Valuation
10.02 %
40,224,756 10.02 % 413 510 p
8.136 %
32,652,000 8.136 % 335 663 p
2.088 %
8,378,057 2.088 % 86 126 p
Oberon Investments Ltd. (GB Investment Management)
1.246 %
5,000,000 1.246 % 51 400 p
Dowgate Wealth Ltd.
0.006524 %
26,183 0.006524 % 269 p

Breakdown by shareholder type

Individuals18.16%
Tekcapital Plc2.09%
Institutional1.25%
Unknown78.5%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals
18.16%
United Kingdom
3.34%

Based on 1000 largest holdings

Logo Belluscura plc
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.
Employees
35